Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia
This study has been completed.
Study NCT00088621   Information provided by Sumitomo Pharmaceuticals America
First Received: July 30, 2004   Last Updated: April 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
SM-13496
Sponsors listed in this trial
Sumitomo Pharmaceuticals America


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services